This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Sen. Tom Harkin Honored For Safeguarding Americans' Right To Choose Complementary Health Care

MILWAUKIE, Ore., March 27, 2013 /PRNewswire/ -- Senator Tom Harkin (D- Iowa) was honored recently by the American Association of Homeopathic Pharmacists (AAHP) with an award of appreciation for introducing and supporting legislation that safeguards Americans' right to choose complementary health care. Chairman of the Senate Health, Education, Labor and Pensions Committee, Senator Harkin is a longtime supporter of patient access to homeopathic medicines.

(Photo: http://photos.prnewswire.com/prnh/20130327/PH84621 )

Mark Land, president of AAHP, said, "We value the Senator's passion for improving people's health and holding down health care costs through healthier living. The AAHP and its members deeply appreciate the Senator's support of homeopathic medicines as a health care choice."

Homeopathic medicines provide relatively low-cost, non-prescription options for self-treatable conditions in the marketplace. They have an extraordinary record of safety for any class of drugs, which encourages a proactive health approach at the first sign of symptom. More than 200 years of successful medical use throughout the world has provided a strong basis of proof for the safety and usefulness of homeopathic medicines, resulting in this therapy being a growing choice among patients and health care professionals alike.

In a March 4 th letter congratulating the members of AAHP on their 90 th anniversary, Senator Harkin recognized the importance of AAHP's mission "to promote responsible industry practices for regulatory compliance, strengthen ingredient product quality, and ensure truthful and compliant product labeling and consumer safety through education outreach."

"Throughout my career in Congress, I have been pleased to work closely with AAHP representatives to ensure that my constituents and all Americans continue to enjoy access to a wide range of personalized homeopathic medicines," wrote Senator Harkin.

Senator Harkin received the plaque from AAHP, the first of its kind presented by the not-for-profit organization, during his visit to the Natural Products Expo West at the Anaheim Convention Center in Calif. on March 8.

Founded in 1923, the AAHP is a not-for-profit corporation of the State Commonwealth of Virginia, representing the interests of homeopathic manufacturers, distributors, and individual pharmacists in cooperative efforts with regulatory agencies and other organizations nationally. The AAHP functions as a trade association within the homeopathic pharmaceutical industry to represent the opinions and interests of homeopathic product manufacturers and distributors, the FDA, other regulatory agencies and other trade associations. In addition, the association promotes high standards in manufacturing and distributing, communicates regulatory changes to member companies through a regular newsletter, and promotes professional communications, education, and research within the homeopathic community.

RELATED LINKS: http://www.homeopathicpharmacy.org

SOURCE American Association of Homeopathic Pharmacists

Copyright 2011 PR Newswire. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 16,915.07 -70.54 -0.42%
S&P 500 1,964.68 -8.15 -0.41%
NASDAQ 4,396.2040 -22.83 -0.52%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto
Advertising Partners

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs